Provider QP85-18 Pharmacy Benefit Update - New Drug-Related PA with QL Criteria: Pseudobulbar Affect (PBA) Read More
Provider QP66-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Noctiva (desmopressin acetate) Read More
Provider QP16-17 Contract Renewal Overlapping with Termination Notices for Interpreter Agencies Read More
Provider QP67-18 Pharmacy Benefit Exclusion for Alferon N (interferon alpha-n3), Cytovene (ganciclovir), Foscarvir (foscarnet), Prevymis (letermovir), Trogarzo (ibalizu,ab-uiyk), Vistide (cidofovir) and Zovirax (actclovir) Read More
